• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Enorama Pharma

0.36 SEK

-1.09 %

Less than 1K followers

ERMA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.09 %
+37.36 %
-41.48 %
-80.94 %
-84.38 %
-85.38 %
-85.90 %
-98.04 %
-94.28 %

Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are sold mainly through retailers who sell the product under their own brand. The largest market is found in the Nordic region, but with a share of sales exported globally. Enorama Pharma was founded in 2006 and the headquarters are located in Malmö.

Read more
Market cap
27.15M SEK
Turnover
7.61K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
19.8.
2026

Interim report Q2'26

18.11.
2026

Interim report Q3'26

17.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/13/2026, 6:30 AM

Notice of annual general meeting of Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release4/7/2026, 1:00 PM

Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)

Enorama Pharma
Regulatory press release3/17/2026, 2:00 PM

Notice of extraordinary general meeting and first control meeting in Enorama Pharma AB (publ)

Enorama Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release3/3/2026, 9:30 AM

Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting

Enorama Pharma
Regulatory press release2/19/2026, 2:00 PM

Notice of extraordinary general meeting in Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2/13/2026, 10:50 AM

Enorama Pharma AB (publ) postpones publication of its 2025 year-end report

Enorama Pharma
Regulatory press release2/13/2026, 10:45 AM

Enorama Pharma AB (publ) decides to prepare a balance sheet for liquidation purposes

Enorama Pharma
Regulatory press release12/2/2025, 1:30 PM

Enorama Pharma: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ENORAMA PHARMA AB (PUBL)

Enorama Pharma
Regulatory press release11/12/2025, 3:00 PM

Notice of extraordinary general meeting in Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release9/25/2024, 10:00 AM

Enorama Pharma AB (publ) Explores Divestment of Nicotine Replacement Therapy Chewing Gum Business

Enorama Pharma